﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Generated by www.ashp.org on Thu, 23 May 2013 03:58:45--><rss version="2.0"><channel><title>ASHP Health-System Pharmacy News</title><link>http://www.ashp.org/menu/News/PharmacyNews.aspx</link><description>ASHP Health-System Pharmacy News</description><language>en-us</language><copyright>Copyright2013 ASHP</copyright><docs>http://cyber.law.harvard.edu/rss/</docs><lastBuildDate>Thu, 23 May 2013 03:58:45</lastBuildDate><image><url>http://www.ashp.org/images/ashprss.gif</url><title>ASHP</title><link>http://www.ashp.org/</link><width>57</width><height>34</height></image><item><title><![CDATA[Sandoz Recalls Preservative-Free Methotrexate]]></title><link>http://www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?Source=News&amp;Type=Rss&amp;Id=3902</link><description><![CDATA[Sandoz on May 20 announced a recall of 40-mL preservative-free methotrexate injection lots CJ4948 and CL0996 because "particulate matter" had been discovered in vials during routine examination of reserve samples.]]></description><category>ASHP News</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?Source=News&amp;Type=Rss&amp;Id=3902</guid><pubDate>Tue, 21 May 2013</pubDate></item><item><title><![CDATA[Radium Isotope Approved for Metastatic Prostate Cancer]]></title><link>http://www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?Source=News&amp;Type=Rss&amp;Id=3901</link><description><![CDATA[FDA today announced the approval of radium Ra 223 dichloride injection for the treatment of symptomatic castration-resistant prostate cancer that has metastasized to the bones but not elsewhere.]]></description><category>ASHP News</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?Source=News&amp;Type=Rss&amp;Id=3901</guid><pubDate>Wed, 15 May 2013</pubDate></item><item><title><![CDATA[Fluticasone–Vilanterol Combination Approved for COPD]]></title><link>http://www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?Source=News&amp;Type=Rss&amp;Id=3900</link><description><![CDATA[FDA on May 10 announced the approval of the Breo Ellipta inhaler, which contains the new long-acting beta2-adrenergic agonist (LABA) vilanterol in combination with fluticasone furoate, for use in adults with chronic obstructive pulmonary disease (COPD).]]></description><category>ASHP News</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?Source=News&amp;Type=Rss&amp;Id=3900</guid><pubDate>Mon, 13 May 2013</pubDate></item><item><title><![CDATA[Compounding Pharmacy Oversight Moves Ahead]]></title><link>http://www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?Source=News&amp;Type=Rss&amp;Id=3899</link><description><![CDATA[Seven months after the emergence of fungal meningitis and other serious infections associated with tainted drugs made by a compounding pharmacy, Congress appears ready to move legislation to bolster FDA's authority over the industry.]]></description><category>ASHP News</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?Source=News&amp;Type=Rss&amp;Id=3899</guid><pubDate>Fri, 10 May 2013</pubDate></item><item><title><![CDATA[Company Recalls Asthmanefrin Device]]></title><link>http://www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?Source=News&amp;Type=Rss&amp;Id=3897</link><description><![CDATA[Japan-based Health &amp; Life Co. Ltd. on May 8 started recalling the atomizer that delivers Asthmanefrin, a nonprescription racepinephrine hydrochloride solution, because a washer could dislodge and become a choking hazard, the drug's manufacturer said.]]></description><category>ASHP News</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?Source=News&amp;Type=Rss&amp;Id=3897</guid><pubDate>Fri, 10 May 2013</pubDate></item><item><title><![CDATA[Prothrombin Complex Concentrate Licensed for Warfarin Reversal]]></title><link>http://www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?Source=News&amp;Type=Rss&amp;Id=3896</link><description><![CDATA[CSL Behring today announced the approval of prothrombin complex concentrate, or Kcentra, for the urgent reversal of acquired coagulation factor deficiency caused by warfarin or another vitamin K antagonist in adults with acute major bleeding.]]></description><category>ASHP News</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?Source=News&amp;Type=Rss&amp;Id=3896</guid><pubDate>Tue, 30 Apr 2013</pubDate></item><item><title><![CDATA[Apotex Recalls Hospira's 40.5-g Piperacillin–Tazobactam for Injection]]></title><link>http://www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?Source=News&amp;Type=Rss&amp;Id=3895</link><description><![CDATA[The Apotex Corp. recall of pharmacy bulk packages of piperacillin and tazobactam for injection now encompasses 15 lots of the antibacterial combination, the company announced April 26.]]></description><category>ASHP News</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?Source=News&amp;Type=Rss&amp;Id=3895</guid><pubDate>Mon, 29 Apr 2013</pubDate></item><item><title><![CDATA[California Bill Would Accord Pharmacists Provider Status]]></title><link>http://www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?Source=News&amp;Type=Rss&amp;Id=3894</link><description><![CDATA[A bill to recognize California pharmacists as "health care providers who have the authority to provide health care services" was introduced on February 21 in the state senate and amended on April 1.]]></description><category>AJHP</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?Source=News&amp;Type=Rss&amp;Id=3894</guid><pubDate>Fri, 26 Apr 2013</pubDate></item><item><title><![CDATA[Pharmacists Work to Boost Patient Satisfaction Scores]]></title><link>http://www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?Source=News&amp;Type=Rss&amp;Id=3893</link><description><![CDATA[The Medicare program's focus on patient satisfaction is providing opportunities for pharmacists to use their medication expertise to help make the hospital stay as pleasant as possible for patients.]]></description><category>ASHP News</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?Source=News&amp;Type=Rss&amp;Id=3893</guid><pubDate>Fri, 26 Apr 2013</pubDate></item><item><title><![CDATA[Virginia Passes Nation's First Biosimilar Substitution Law]]></title><link>http://www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?Source=News&amp;Type=Rss&amp;Id=3892</link><description><![CDATA[The state of Virginia on March 16 became the first in the nation to pass a law regarding biosimilars, a move that precedes the availability of these products on the U.S. market.]]></description><category>ASHP News</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?Source=News&amp;Type=Rss&amp;Id=3892</guid><pubDate>Fri, 26 Apr 2013</pubDate></item></channel></rss>